Check out our most popular compounded medications! Get Started
This Dexamethasone Sodium Phosphate 1.6 mg/mL and Verapamil HCl 1 mg/mL solution is a specialized liquid formulation designed for use in iontophoresis therapy. By applying an electric current, this solution facilitates the transdermal delivery of medication through the skin, providing targeted treatment for conditions such as inflammation, pain management, and localized drug delivery for musculoskeletal disorders.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This specialized liquid formulation combines Dexamethasone Sodium Phosphate at a concentration of 1.6 mg/mL and Verapamil Hydrochloride at 1 mg/mL, designed specifically for iontophoresis therapy. Iontophoresis is a non-invasive method that uses a mild electric current to enhance the transdermal delivery of medications, allowing the active ingredients to penetrate deeper into the targeted tissues.
Dexamethasone Sodium Phosphate is a potent corticosteroid with anti-inflammatory properties. It helps reduce inflammation by inhibiting multiple inflammatory cytokines, leading to decreased edema, erythema, and pain in affected areas. Verapamil Hydrochloride is a calcium channel blocker that not only aids in vasodilation but also has been shown to influence collagen synthesis, which can be beneficial in conditions involving fibrotic tissue.
The combination of these two medications delivered via iontophoresis allows for localized treatment of various musculoskeletal and soft tissue conditions. This includes tendinitis, bursitis, plantar fasciitis, and localized inflammatory or fibrotic disorders. The electric current facilitates the movement of the
Dexamethasone Sodium Phosphate and Verapamil HCl are both active pharmaceutical ingredients that can interact with other medications, potentially altering their effects or increasing the risk of adverse reactions. When used in a specialized liquid formulation for iontophoresis, these interactions may still be relevant, even though the systemic absorption is generally lower compared to oral or intravenous administration. It is crucial for both patients and prescribers to be aware of these potential interactions to ensure appropriate treatment.
Dexamethasone Sodium Phosphate is a corticosteroid that can interact with a variety of medications. It may enhance the effects of anticoagulants, increasing the risk of bleeding. Concurrent use with nonsteroidal anti-inflammatory drugs (NSAIDs) can increase the risk of gastrointestinal ulcers or bleeding. Dexamethasone may also reduce the effectiveness of vaccines and should be used cautiously in patients receiving immunizations. Additionally, it can interact with medications that affect electrolyte balance, such as diuretics, leading to potential imbalances in potassium or sodium levels.
Verapamil HCl, a calcium channel blocker, can interact with other cardiovascular drugs, such as beta-blockers, leading to an increased risk of bradycardia, hypotension, or heart block. It may also interact with digoxin, increasing the risk of digoxin toxicity. Verapamil can inhibit the metabolism of certain drugs metabolized by the liver enzyme CYP3A4, such as statins, leading to increased plasma concentrations and potential toxicity. Caution is advised when used with other medications that lower blood pressure, as this can result in additive hypotensive effects.
When considering the use of this iontophoresis formulation, it is important to evaluate the patient's current medication regimen for potential interactions. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements. Prescribers should carefully assess the risk-benefit ratio of using this formulation in patients with complex medication profiles or those with underlying health conditions that may predispose them to adverse interactions.
While the localized delivery of this formulation via iontophoresis may reduce systemic exposure, the potential for drug interactions should not be overlooked. Monitoring for signs of adverse reactions or changes in the effectiveness of concurrent medications is recommended. If you have any questions or concerns about potential drug interactions with this formulation, please reach out to us for further guidance and support.
The Dexamethasone Sodium Phosphate 1.6 mg/mL/Verapamil HCl 1 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed to enhance the delivery of medication through the skin using iontophoresis therapy. Iontophoresis is a non-invasive technique that employs a mild electric current to drive charged drug molecules across the dermal barrier, allowing for targeted and localized treatment. This method is particularly beneficial for conditions requiring precise drug delivery, such as pain management, inflammation reduction, and other localized therapeutic needs.
Dexamethasone Sodium Phosphate is a potent corticosteroid with anti-inflammatory properties. It works by inhibiting the release of substances in the body that cause inflammation, thereby reducing swelling, redness, and pain in the affected area. When used in iontophoresis, dexamethasone is delivered directly to the site of inflammation, maximizing its therapeutic effects while minimizing systemic exposure and potential side effects associated with oral or injectable corticosteroids.
Verapamil HCl, on the other hand, is a calcium channel blocker that is commonly used to treat cardiovascular conditions. In the context of iontophoresis, verapamil is utilized for its ability to relax smooth muscle tissue and improve blood flow. This can be particularly useful in conditions where muscle relaxation and increased circulation are desired, such as in the treatment of muscle spasms or localized ischemia. Additionally, verapamil may enhance the penetration of dexamethasone by altering the permeability of the skin barrier.
The combination of these two active ingredients in a single iontophoresis solution allows for a synergistic approach to treatment. The electric current used in iontophoresis not only facilitates the transdermal delivery of these medications but also ensures that they are concentrated at the site of action. This targeted delivery system is advantageous for patients who require localized treatment without the systemic effects of oral medications.
For prescribers, this formulation offers a versatile option for managing a variety of conditions that benefit from localized drug delivery. It is important to assess the patient's specific needs and the suitability of iontophoresis therapy for their condition. The use of this formulation should be considered in cases where traditional methods of drug delivery are inadequate or when a rapid onset of action is required.
Patients using this formulation can expect a non-invasive treatment experience with minimal discomfort. The iontophoresis procedure is generally well-tolerated, and the risk of adverse effects is low due to the localized nature of the therapy. However, it is essential for patients to follow the prescribed treatment regimen and report any unusual symptoms to their healthcare provider.
If you have any questions about this formulation or its use in iontophoresis therapy, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to ensure the best possible outcomes for your treatment.
This is a specialized liquid formulation used in iontophoresis therapy, where an electric current is applied to facilitate the transdermal delivery of medication through the skin. It is designed for targeted treatment of various conditions, such as pain management or localized drug delivery.
Iontophoresis uses a mild electric current to drive the Dexamethasone Sodium Phosphate and Verapamil HCl through the skin, enhancing the absorption of these medications directly to the affected area, which can improve treatment efficacy and reduce systemic side effects.
This formulation is often used for conditions requiring localized treatment, such as inflammation, pain management, and certain musculoskeletal disorders. It may also be used for other conditions as determined by a healthcare provider.
Common side effects may include skin irritation or redness at the site of application. More serious side effects are rare but should be reported to a healthcare provider immediately. Always consult with a healthcare professional before starting treatment.
Individuals with known allergies to Dexamethasone, Verapamil, or any other components of the formulation should avoid use. It is also not recommended for individuals with certain medical conditions or those who have implanted electronic devices. Consult a healthcare provider for a full assessment.
The solution is applied to the skin at the treatment site, and electrodes are placed to deliver a mild electric current. The process is typically conducted by a healthcare professional in a clinical setting to ensure proper application and dosage.
A typical iontophoresis session can last anywhere from 10 to 30 minutes, depending on the condition being treated and the specific protocol recommended by the healthcare provider.
While some iontophoresis devices are available for home use, it is crucial to have a healthcare provider's guidance to ensure appropriate treatment. They can provide instructions and monitor progress to avoid complications.
The frequency of treatments depends on the condition being treated and the response to therapy. A healthcare provider will determine the appropriate treatment schedule, which may range from several times a week to less frequent sessions.
Coverage for iontophoresis treatments and the associated medications can vary by insurance plan. It is advisable to check with your insurance provider to determine if this treatment is covered under your policy.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
